SCHEMBL18979320

SCHEMBL18979320

CCCCCCCCCCCCCCC(CCC)OC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 1/20 0.51
PNLIP P16233 3/20 0.47
CTSK P43235 1/20 0.47
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
LMNA P02545 2/20 0.46
PRSS1 P07477 3/20 0.46
CTSG P08311 2/20 0.46
CTRB1 P17538 2/20 0.46
CMA1 P23946 2/20 0.46
PRKCA P17252 2/20 0.46
PRKCD Q05655 2/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
TSHR P16473 2/20 0.46
ALOX12 P18054 1/20 0.46
NAAA Q02083 1/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18979349 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979317 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979318 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979351 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979275 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979328 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979306 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979325 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL18979347 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK
SCHEMBL1219015 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1PNLIPCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180219160-A1 BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME UBE INDUSTRIES, LTD. (JP) 2018-08-02 US disclosed
EP-3181569-A1 BENZOBIS(THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME UBE Industries, Ltd. (JP) 2017-06-21 EP disclosed
CN-105567257-A Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element CHI MEI CORP 2016-05-11 CN disclosed
CN-103131430-B The formation method of crystal aligning agent, liquid crystal orienting film and liquid crystal display device JSR CO., LTD. (JP) 2015-08-05 CN disclosed
CN-103131430-A Liquid crystal aligning agent, forming method for liquid crystal alignment film, and liquid crystal display device JSR CORP 2013-06-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180219160-A1 BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME IKZF3, HELZ, TEC MEN1 3053/4885KMT2A 1595/4885ALDH1A1 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.